Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.
- 16 July 2001
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 26 (2) , 301-311
- https://doi.org/10.1016/s0731-7085(01)00410-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Clozapine and Metabolite Concentrations during Treatment of Patients with Chronic SchizophreniaThe Journal of Clinical Pharmacology, 1999
- Characterization of metabolites of clozapine N-oxide in the rat by micro-column high performance liquid chromatography/mass spectrometry with electrospray interfaceJournal of Pharmaceutical and Biomedical Analysis, 1996
- Decomposition of ClozapineN-Oxide in the Qualitative and Quantitative Analysis of Clozapine and its MetabolitesJournal of Pharmaceutical Sciences, 1994
- The Safety and Efficacy of Clozapine in Severe Treatment-Resistant Schizophrenic Patients in the UKThe British Journal of Psychiatry, 1993
- ClozapineNew England Journal of Medicine, 1991
- The Assay of Clozapine and N-Desmethylclozapine in Human Plasma by High-Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1991
- High-performance liquid chromatographic procedure for the determination of clozapine, haloperidol, droperidol and several benzodiazepines in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- Development of the Clozaril Patient Management SystemPsychopharmacology, 1989
- Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Non‐equilibrium Method for the Radioimmunoassay of Clozapine in the Presence of MetabolitesEuropean Journal of Biochemistry, 1977